| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 71, 1416-1420, Copyright © 1990 by Endocrine Society
ARTICLES |
CA Landis, G Harsh, J Lyons, RL Davis, F McCormick and HR Bourne
Department of Medicine, University of California, San Francisco 94143.
Activating mutations in the gene for the alpha-chain of Gs, the stimulatory regulator of adenylyl cyclase, have been identified in human GH-secreting pituitary tumors. Using the polymerase chain reaction and allele-specific oligonucleotide hybridization, we screened 25 GH-secreting tumors for the presence of the activating mutations. We also reviewed the clinical charts of the patients from whom the tumors were removed. Of 25 tumors, 10 (40%) contained activating mutations. Patients in the mutation-positive group came to surgery with smaller tumors and had lower GH levels. The activating mutations identify a subgroup of GH-secreting pituitary tumors that probably arise from a shared oncogenic mechanism.
This article has been cited by other articles:
![]() |
I. Donangelo, S. Gutman, E. Horvath, K. Kovacs, K. Wawrowsky, M. Mount, and S. Melmed Pituitary Tumor Transforming Gene Overexpression Facilitates Pituitary Tumor Development Endocrinology, October 1, 2006; 147(10): 4781 - 4791. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Adarichev, R. Vaiskunaite, J. Niu, I. V. Balyasnikova, and T. A. Voyno-Yasenetskaya G{alpha}13-mediated transformation and apoptosis are permissively dependent on basal ERK activity Am J Physiol Cell Physiol, October 1, 2003; 285(4): C922 - C934. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O. Akintoye, C. Chebli, S. Booher, P. Feuillan, H. Kushner, D. Leroith, N. Cherman, P. Bianco, S. Wientroub, P. G. Robey, et al. Characterization of gsp-Mediated Growth Hormone Excess in the Context of McCune-Albright Syndrome J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5104 - 5112. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Kineman, L. T. Teixeira, G. V. Amargo, K. T. Coschigano, J. J. Kopchick, and L. A. Frohman The Effect of GHRH on Somatotrope Hyperplasia and Tumor Formation in the Presence and Absence of GH Signaling Endocrinology, September 1, 2001; 142(9): 3764 - 3773. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Peri, B. Conforti, S. Baglioni-Peri, P. Luciani, F. Cioppi, L. Buci, S. Corbetta, E. Ballaré, M. Serio, and A. Spada Expression of Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Responsive Element Binding Protein and Inducible-cAMP Early Repressor Genes in Growth Hormone-Secreting Pituitary Adenomas with or without Mutations of the Gs{{alpha}} Gene J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2111 - 2117. [Abstract] [Full Text] |
||||
![]() |
A. Barlier, I. Pellegrini-Bouiller, G. Gunz, A. J. Zamora, P. Jaquet, and A. Enjalbert Impact of gsp Oncogene on the Expression of Genes Coding for Gs{alpha}, Pit-1, Gi2{alpha}, and Somatostatin Receptor 2 in Human Somatotroph Adenomas: Involvement in Octreotide Sensitivity J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2759 - 2765. [Abstract] [Full Text] |
||||
![]() |
S. L. Asa and S. Ezzat The Cytogenesis and Pathogenesis of Pituitary Adenomas Endocr. Rev., December 1, 1998; 19(6): 798 - 827. [Abstract] [Full Text] |
||||
![]() |
A. Barlier, G. Gunz, A. J. Zamora, I. Morange-Ramos, D. Figarella-Branger, H. Dufour, A. Enjalbert, and P. Jaquet Pronostic and Therapeutic Consequences of Gs{alpha} Mutations in Somatotroph Adenomas J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1604 - 1610. [Abstract] [Full Text] |
||||
![]() |
A. Lania, L. Persani, E. Ballaré, S. Mantovani, M. Losa, and A. Spada Constitutively Active Gs{alpha} Is Associated with an Increased Phosphodiesterase Activity in Human Growth Hormone-Secreting Adenomas J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1624 - 1628. [Abstract] [Full Text] |
||||
![]() |
S. R. Peacey, A. A. Toogood, and S. M. Shalet Hypothalamic Dysfunction in "Cured" Acromegaly Is Treatment Modality Dependent J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1682 - 1686. [Abstract] [Full Text] |
||||
![]() |
M. Daniely, A. Aviram, E. F. Adams, M. Buchfelder, G. Barkai, R. Fahlbusch, B. Goldman, and E. Friedman Comparative Genomic Hybridization Analysis of Nonfunctioning Pituitary Tumors J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1801 - 1805. [Abstract] [Full Text] |
||||
![]() |
I. Shimon and S. Melmed Pituitary Tumor Pathogenesis J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1675 - 1681. [Full Text] [PDF] |
||||
![]() |
C. L. Boguszewski, G. Johannsson, B.-A. Bengtsson, A. Johansson, B. Carlsson, and L. M. S. Carlsson Circulating Non-22-Kilodalton Growth Hormone Isoforms in Acromegalic Men before and after Transsphenoidal Surgery J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1516 - 1521. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |